Projects

Descriptive study of Cytomegalovirus infection in a tertiary care centre in South India

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - Ongoing

Project Lead

Ms. Sharon Leah S

Authors

Ms. Sharon Leah S, Dr Mamatha V, Dr. Sneha May Kurian, Dr. Medha Alexander

Project Status

completed

Project Type

Descriptive study